View in EDS

Bismuth dithiocarbamate complexes as anticancer agents and beyond: a comprehensive review.

Saved in:
Bibliographic Details
Title: Bismuth dithiocarbamate complexes as anticancer agents and beyond: a comprehensive review.
Authors: Verma, Deepika1 (AUTHOR), Gupta, Kiran1 (AUTHOR), Mir, Snober S.2 (AUTHOR), Prakash, Om1 (AUTHOR) ops92002@gmail.com
Source: Dalton Transactions: An International Journal of Inorganic Chemistry. 7/28/2025, Vol. 54 Issue 28, p10830-10846. 17p.
Subjects: Antineoplastic agents, Tumor growth, Anti-infective agents, Drug resistance in cancer cells, Apoptosis, Biochemistry, Chemical synthesis, Bismuth compounds
Abstract: Bismuth dithiocarbamate (Bi-DTC) complexes have emerged as promising candidates in the fight against cancer, attributed to their unique mechanisms of action and low toxicity compared to traditional metal-based therapies. With their sulfur-rich coordination sites, the dithiocarbamate (DTC) ligands facilitate versatile binding and structural diversity, enabling the formation of supramolecular assemblies with potent biological activity. While bismuth itself does not naturally exhibit biological functions, its dithiocarbamate derivatives have demonstrated notable efficacy as anticancer agents and antimicrobial and antiparasitic properties. In vitro and in vivo studies reveal that bismuth dithiocarbamates (Bi-DTC) can effectively induce apoptosis, suppress tumour growth, and overcome chemoresistance, positioning them as innovative therapeutic options. This review examines the synthesis strategies, biological mechanisms, and experimental evidence supporting the anticancer potential of these complexes. It also highlights their antimicrobial and antileishmanial activities, emphasising the role of antimicrobial properties in preventive and supportive therapies during cancer treatment. However, further investigations are essential to delineate their mechanisms of action and optimise their clinical applicability for cancer treatment. [ABSTRACT FROM AUTHOR]
Copyright of Dalton Transactions: An International Journal of Inorganic Chemistry is the property of Royal Society of Chemistry and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Description
Abstract:Bismuth dithiocarbamate (Bi-DTC) complexes have emerged as promising candidates in the fight against cancer, attributed to their unique mechanisms of action and low toxicity compared to traditional metal-based therapies. With their sulfur-rich coordination sites, the dithiocarbamate (DTC) ligands facilitate versatile binding and structural diversity, enabling the formation of supramolecular assemblies with potent biological activity. While bismuth itself does not naturally exhibit biological functions, its dithiocarbamate derivatives have demonstrated notable efficacy as anticancer agents and antimicrobial and antiparasitic properties. In vitro and in vivo studies reveal that bismuth dithiocarbamates (Bi-DTC) can effectively induce apoptosis, suppress tumour growth, and overcome chemoresistance, positioning them as innovative therapeutic options. This review examines the synthesis strategies, biological mechanisms, and experimental evidence supporting the anticancer potential of these complexes. It also highlights their antimicrobial and antileishmanial activities, emphasising the role of antimicrobial properties in preventive and supportive therapies during cancer treatment. However, further investigations are essential to delineate their mechanisms of action and optimise their clinical applicability for cancer treatment. [ABSTRACT FROM AUTHOR]
ISSN:14779226
DOI:10.1039/d5dt00656b